AAAAAA
Results: 1-25/34
Authors:
Barter, PJ
Sacks, FM
Citation: Pj. Barter et Fm. Sacks, Threshold level or not for low-density lipoprotein cholesterol, AM J M CARE, 7(5), 2001, pp. S125-S131
Authors:
Tomiyasu, K
Walsh, BW
Ikewaki, K
Judge, H
Sacks, FM
Citation: K. Tomiyasu et al., Differential metabolism of human VLDL according to content of ApoE and ApoC-III, ART THROM V, 21(9), 2001, pp. 1494-1500
Authors:
Svetkey, LP
Moore, TJ
Simons-Morton, DG
Appel, LJ
Bray, GA
Sacks, FM
Ard, JD
Mortensen, RM
Mitchell, SR
Conlin, PR
Kesari, M
Citation: Lp. Svetkey et al., Angiotensinogen genotype and blood pressure response in the Dietary Approaches to Stop Hypertension (DASH) study, J HYPERTENS, 19(11), 2001, pp. 1949-1956
Authors:
Sacks, FM
Citation: Fm. Sacks, Atorvastatin for acute coronary syndromes - Reply, J AM MED A, 286(5), 2001, pp. 534-535
Authors:
Campos, H
Moye, LA
Glasser, SP
Stampfer, MJ
Sacks, FM
Citation: H. Campos et al., Low-density lipoprotein size, pravastatin treatment, and coronary events, J AM MED A, 286(12), 2001, pp. 1468-1474
Authors:
Sacks, FM
Citation: Fm. Sacks, Lipid-lowering therapy in acute coronary syndromes, J AM MED A, 285(13), 2001, pp. 1758-1760
Authors:
Sacks, FM
Porschan, MA
Svetkey, LP
Citation: Fm. Sacks et al., Dietary sodium and blood pressure. Reply, N ENG J MED, 344(22), 2001, pp. 1718-1719
Authors:
Sacks, FM
Svetkey, LP
Vollmer, WM
Appel, LJ
Bray, GA
Harsha, D
Obarzanek, E
Conlin, PR
Miller, ER
Simons-Morton, DG
Karanja, N
Lin, PH
Citation: Fm. Sacks et al., Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet., N ENG J MED, 344(1), 2001, pp. 3-10
Authors:
Campos, H
Perlov, D
Khoo, C
Sacks, FM
Citation: H. Campos et al., Distinct patterns of lipoproteins with apoB defined by presence of apoE orapoC-III in hypercholesterolemia and hypertriglyceridemia, J LIPID RES, 42(8), 2001, pp. 1239-1249
Authors:
Obarzanek, E
Sacks, FM
Vollmer, RM
Bray, GA
Miller, ER
Lin, PH
Karanja, NM
Most-Windhauser, MM
Moore, TJ
Swain, JF
Bales, CW
Proschan, MA
Citation: E. Obarzanek et al., Effects on blood lipids of a blood pressure-lowering diet: the Dietary Approaches to Stop Hypertension (DASH) Trial, AM J CLIN N, 74(1), 2001, pp. 80-89
Authors:
Bray, PF
Cannon, CP
Goldschmidt-Clermont, P
Moye, LA
Pfeffer, MA
Sacks, FM
Braunwald, E
Citation: Pf. Bray et al., The platelet Pl(A2) and angiotensin-converting enzyme (ACE) D allele polymorphisms and the risk of recurrent events after acute myocardial infarction, AM J CARD, 88(4), 2001, pp. 347-352
Authors:
Tsevat, J
Kuntz, KM
Orav, EJ
Weinstein, MC
Sacks, FM
Goldman, L
Citation: J. Tsevat et al., Cost-effectiveness of pravastatin therapy for survivors of myocardial infarction with average cholesterol levels, AM HEART J, 141(5), 2001, pp. 727-734
Authors:
Conlin, PR
Chow, D
Miller, ER
Svetkey, LP
Lin, PH
Harsha, DW
Moore, TJ
Sacks, FM
Appel, LJ
Citation: Pr. Conlin et al., The effect of dietary patterns on blood pressure control in hypertensive patients: Results from the Dietary Approaches to Stop Hypertension (DASH) trial, AM J HYPERT, 13(9), 2000, pp. 949-955
Authors:
Sacks, FM
Alaupovic, P
Moye, LA
Cole, TG
Sussex, B
Stampfer, MJ
Pfeffer, MA
Braunwald, E
Citation: Fm. Sacks et al., VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial, CIRCULATION, 102(16), 2000, pp. 1886-1892
Authors:
Sacks, FM
Tonkin, AM
Shepherd, J
Braunwald, E
Cobbe, S
Hawkins, CM
Keech, A
Packard, C
Simes, J
Byington, R
Furberg, CD
Citation: Fm. Sacks et al., Effect of pravastatin on coronary disease events in subgroups defined by coronary risk factors - The prospective pravastatin pooling project, CIRCULATION, 102(16), 2000, pp. 1893-1900
Authors:
Sacks, FM
Pfeffer, MA
Moye, LA
Hawkins, CM
Davis, BR
Rouleau, JL
Cole, TG
Braunwald, E
Citation: Fm. Sacks et al., Cholesterol and recurrent events trial (CARE) - The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels, CHOLESTEROL-LOWERING THERAPY, 2000, pp. 63-89
Authors:
Flaker, GC
Warnica, JW
Sacks, FM
Moye, LA
Davis, BR
Rouleau, JL
Webel, RR
Pfeffer, MA
Braunwald, E
Citation: Gc. Flaker et al., Pravastatin prevents clinical events in revascularized patients with average cholesterol concentrations, J AM COL C, 34(1), 1999, pp. 106-112
Authors:
Sacks, FM
Lewis, SJ
Pouleur, H
Braunwald, E
Citation: Fm. Sacks et al., "Care," cancer and coenzyme Q10 - Reply, J AM COL C, 33(3), 1999, pp. 898-899
Authors:
Pfeffer, MA
Sacks, FM
Moye, LA
East, C
Goldman, S
Nash, DT
Rouleau, JR
Rouleau, JL
Sussex, BA
Theroux, P
Citation: Ma. Pfeffer et al., Influence of baseline lipids on effectiveness of pravastatin in the CARE trial, J AM COL C, 33(1), 1999, pp. 125-130
Authors:
Sacks, FM
Ridker, PM
Citation: Fm. Sacks et Pm. Ridker, Lipid lowering and beyond: Results from the CARE study on lipoproteins andinflammation, HERZ, 24(1), 1999, pp. 51-56
Authors:
Moore, TJ
Vollmer, WM
Appel, LJ
Sacks, FM
Svetkey, LP
Vogt, TM
Conlin, PR
Simons-Morton, DG
Carter-Edwards, L
Harsha, DW
Citation: Tj. Moore et al., Effect of dietary patterns on ambulatory blood pressure - Results from theDietary Approaches to Stop Hypertension (DASH) Trial, HYPERTENSIO, 34(3), 1999, pp. 472-477
Authors:
Sacks, FM
Appel, LJ
Moore, TJ
Obarzanek, E
Vollmer, WM
Svetkey, LP
Bray, GA
Vogt, TM
Cutler, JA
Windhauser, MM
Lin, PH
Karanja, N
Citation: Fm. Sacks et al., A dietary approach to prevent hypertension: A review of the Dietary Approaches to Stop Hypertension (DASH) study, CLIN CARD, 22(7), 1999, pp. 6-10
Authors:
Khoo, C
Campos, H
Judge, H
Sacks, FM
Citation: C. Khoo et al., Effects of estrogenic oral contraceptives on the lipoprotein B particle system defined by apolipoproteins E and C-III content, J LIPID RES, 40(2), 1999, pp. 202-212
Authors:
Walsh, BW
Spiegelman, D
Morrissey, M
Sacks, FM
Citation: Bw. Walsh et al., Relationship between serum estradiol levels and the increases in high-density lipoprotein levels in postmenopausal women treated with oral estradiol, J CLIN END, 84(3), 1999, pp. 985-989
Authors:
Plehn, JF
Davis, BR
Sacks, FM
Rouleau, JL
Pfeffer, MA
Bernstein, V
Cuddy, TE
Moye, LA
Piller, LB
Rutherford, J
Simpson, LM
Braunwald, E
Citation: Jf. Plehn et al., Reduction of stroke incidence after myocardial infarction with pravastatin- The cholesterol and recurrent events (CARE) study, CIRCULATION, 99(2), 1999, pp. 216-223